Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma (vol 76, pg 853, 2016)

P Moreau; NWCJ v.d. Donk; JS Miguel; H Lokhorst; H Nahi; D Ben-Yehuda; M Cavo; G Cook; M Delforge; H Einsele; S Zweegman; H Ludwig; C Driessen; A Palumbo; T Facon; T Plesner; M Dimopoulos; P Sondergeld; Pieter Sonneveld; MV Mateos

doi:10.1007/s40265-016-0590-3

Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma (vol 76, pg 853, 2016)

P Moreau, NWCJ v.d. Donk, JS Miguel, H Lokhorst, H Nahi, D Ben-Yehuda, M Cavo, G Cook, M Delforge, H Einsele, S Zweegman, H Ludwig, C Driessen, A Palumbo, T Facon, T Plesner, M Dimopoulos, P Sondergeld, Pieter Sonneveld, MV Mateos

Hematology

Research output: Contribution to journal › Article › Academic › peer-review

1 Citation (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	989-990
Number of pages	2
Journal	Drugs
Volume	76
Issue number	9
DOIs	https://doi.org/10.1007/s40265-016-0590-3
Publication status	Published - 2016

Research programs

EMC MM-02-41-03

Access to Document

10.1007/s40265-016-0590-3

Cite this

Moreau, P., v.d. Donk, NWCJ., Miguel, JS., Lokhorst, H., Nahi, H., Ben-Yehuda, D., Cavo, M., Cook, G., Delforge, M., Einsele, H., Zweegman, S., Ludwig, H., Driessen, C., Palumbo, A., Facon, T., Plesner, T., Dimopoulos, M., Sondergeld, P., Sonneveld, P., & Mateos, MV. (2016). Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma (vol 76, pg 853, 2016). Drugs, 76(9), 989-990. https://doi.org/10.1007/s40265-016-0590-3

@article{e234a9bbec044d928ce8c22fc0acea4e,

title = "Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma (vol 76, pg 853, 2016)",

author = "P Moreau and {v.d. Donk}, NWCJ and JS Miguel and H Lokhorst and H Nahi and D Ben-Yehuda and M Cavo and G Cook and M Delforge and H Einsele and S Zweegman and H Ludwig and C Driessen and A Palumbo and T Facon and T Plesner and M Dimopoulos and P Sondergeld and Pieter Sonneveld and MV Mateos",

year = "2016",

doi = "10.1007/s40265-016-0590-3",

language = "Undefined/Unknown",

volume = "76",

pages = "989--990",

journal = "Drugs",

issn = "0012-6667",

publisher = "Adis",

number = "9",

}

Moreau, P, v.d. Donk, NWCJ, Miguel, JS, Lokhorst, H, Nahi, H, Ben-Yehuda, D, Cavo, M, Cook, G, Delforge, M, Einsele, H, Zweegman, S, Ludwig, H, Driessen, C, Palumbo, A, Facon, T, Plesner, T, Dimopoulos, M, Sondergeld, P, Sonneveld, P & Mateos, MV 2016, 'Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma (vol 76, pg 853, 2016)', Drugs, vol. 76, no. 9, pp. 989-990. https://doi.org/10.1007/s40265-016-0590-3

TY - JOUR

T1 - Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma (vol 76, pg 853, 2016)

AU - Moreau, P

AU - v.d. Donk, NWCJ

AU - Miguel, JS

AU - Lokhorst, H

AU - Nahi, H

AU - Ben-Yehuda, D

AU - Cavo, M

AU - Cook, G

AU - Delforge, M

AU - Einsele, H

AU - Zweegman, S

AU - Ludwig, H

AU - Driessen, C

AU - Palumbo, A

AU - Facon, T

AU - Plesner, T

AU - Dimopoulos, M

AU - Sondergeld, P

AU - Sonneveld, Pieter

AU - Mateos, MV

PY - 2016

Y1 - 2016

U2 - 10.1007/s40265-016-0590-3

DO - 10.1007/s40265-016-0590-3

M3 - Article

C2 - 27206917

SN - 0012-6667

VL - 76

SP - 989

EP - 990

JO - Drugs

JF - Drugs

IS - 9

ER -